OncologyPharmacist.net
Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
Oncology Pharmacist Online Resources

Welcome

OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP


Links of Interest

www.usp.org CSP and chemo safety guidelines
www.jointcommission.org Safety goals
www.nccn.org Chemo guidelines
www.asco.org Chemo guidelines
www.ashp.org Chemo and safety guidelines
www.pharmecology.com Wast Stream Management Guidelines
www.fda.gov/Safety/MedWatch/default.htm MedWatch reporting program
oncologypharmacist.net Consulting services and practice sites
www.hoparx.org Hematology/Oncology Pharmacy Association
chemorders.com Chemotherapy Order Templates
Postmarket Safety Information For Patients and Providers
anti-cancerdrugs.com Lippincott Williams & Wilkins
BioMedSearch.com Biomedical Search Engine

Newsfeed

Cancer / Oncology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

Snus use in Norway has tripled in five years
The increase in Scandinavian snus consumption in Norway is highest among young people, according to a new report from the Norwegian Institute of Public Health.
Key factor discovered in the progression of liver cancer
One of the most aggressive and common forms of liver cancer is hepatocellular carcinoma.
Researchers identify biological indicator of response to new ovarian cancer drug
Researchers have found a way of identifying which ovarian cancer patients are likely to respond well to a new anti-cancer drug called rucaparib.
Early results show response to new drug in patients with lymphomas and advanc...
Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
How new insight into cells could lead to better drugs
A new insight into immune cells by scientists at The University of Manchester could lead to more effective drug treatments.

Newsfeed display by CaRP

Search:

Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net  
privacy statement | terms of service